Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference

References

• Biere B, Bauer B, Schweiger B. Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR. J. Clin. Microbiol.48(4), 1425–1427 (2010).
   PubMed Web of Science ®Google Scholar
• Levandowski RA, Regnery HL, Staton E, Burgess BG, Williams MS, Groothuis JR. Antibody responses to influenza B viruses in immunologically unprimed children. Pediatrics88(5), 1031–1036 (1991).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine28(9), 2149–2156 (2010).
   PubMed Web of Science ®Google Scholar
• Wagner RR. Viral interference. Some considerations of basic mechanisms and their potential relationship to host resistance. Bacteriol. Rev.24(1), 151–166 (1960).
   PubMedGoogle Scholar
• Dagan R, Poolman J, Siegrist CA. Glycoconjugate vaccines and immune interference: a review. Vaccine28(34), 5513–5523 (2010).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Gruber WC, Mendelman PM et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis.181(3), 1133–1137 (2000).
   PubMed Web of Science ®Google Scholar
• Gruber WC, Kirschner K, Tollefson S et al. Comparison of monovalent and trivalent live attenuated influenza vaccines in young children. J. Infect. Dis.168(1), 53–60 (1993).
   PubMedGoogle Scholar
• Hjorth RN, Cholodofsky S, Yannarell DA. Laboratory models for possible factors influencing cold-adapted influenza virus vaccine immunogenicity: host range, temperature sensitivity, and interference. Vaccine Res.5(3), 137–147 (1996).
   Google Scholar
• Smith H, Sweet C. Lessons for human influenza from pathogenicity studies with ferrets. Rev. Infect. Dis.10(1), 56–75 (1988).
   PubMedGoogle Scholar
• Potter CW, Jennings R, Clark A, Ali M. Interference following dual inoculation with influenza A (H3N2) and (H1N1) viruses in ferrets and volunteers. J. Med. Virol.11(1), 77–86 (1983).
   PubMedGoogle Scholar
• Woo JC, Ambrose CS. Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines. Influenza Other Respi. Viruses3(6), 257–259 (2009).
   PubMedGoogle Scholar
• Murphy BR, Coelingh K. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol.15(2), 295–323 (2002).
   PubMed Web of Science ®Google Scholar
• Atmar RL, Keitel WA, Cate TR, Quarles JM, Couch RB. Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults. J. Infect. Dis.172(1), 253–257 (1995).
   PubMedGoogle Scholar
• Gruber WC, Belshe RB, King JC et al. Evaluation of live attenuated influenza vaccines in children 6–18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group. J. Infect. Dis.173(6), 1313–1319 (1996).
   PubMed Web of Science ®Google Scholar
• Keitel WA, Couch RB, Quarles JM, Cate TR, Baxter B, Maassab HF. Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults. J. Infect. Dis.167(2), 305–311 (1993).
   PubMedGoogle Scholar
• Gruber WC. Factors important in ensuring immunogenicity of multivalent ca influenza vaccines in young children. In: Factors Important In Ensuring Immunogenicity Of Multivalent Ca Influenza Vaccines In Young Children. Hampson AW, Webster RG, Brown LE (Eds). Elsevier, Amsterdam, The Netherlands, 622–627 (1996).
   Google Scholar
• Gruber WC, Campbell PW, Thompson JM, Reed GW, Roberts B, Wright PF. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. J. Infect. Dis.169(2), 241–247 (1994).
   PubMedGoogle Scholar
• Piedra PA, Glezen WP, Mbawuike I et al. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children. Vaccine11(7), 718–724 (1993).
   PubMedGoogle Scholar
• Swierkosz EM, Newman FK, Anderson EL, Nugent SL, Mills GB, Belshe RB. Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children. J. Infect. Dis.169(5), 1121–1124 (1994).
   PubMedGoogle Scholar
• Belshe RB, Swierkosz EM, Anderson EL, Newman FK, Nugent SL, Maassab HF. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine. J. Infect. Dis.165(4), 727–732 (1992).
   PubMedGoogle Scholar
• Miyazaki C, Nakayama M, Tanaka Y et al. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines. Vaccine11(8), 853–858 (1993).
   PubMedGoogle Scholar
• Murphy BR, Clements ML. The systemic and mucosal immune response of humans to influenza A virus. Curr. Top. Microbiol. Immunol.146, 107–116 (1989).
   PubMed Web of Science ®Google Scholar
• Tam JS, Capeding MR, Lum LC et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr. Infect. Dis. J.26(7), 619–628 (2007).
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Yi T, Walker RE, Connor EM. Duration of protection provided by live attenuated influenza vaccine in children. Pediatr. Infect. Dis. J.27(8), 744–748 (2008).
   PubMedGoogle Scholar
• Vesikari T, Fleming DM, Aristegui JF et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics118(6), 2298–2312 (2006).
   PubMed Web of Science ®Google Scholar
• Rhorer J, Ambrose CS, Dickinson S et al. Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials. Vaccine27(7), 1101–1110 (2009).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Mendelman PM, Treanor J et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N. Engl. J. Med.338(20), 1405–1412 (1998).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Gruber WC, Mendelman PM et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J. Pediatr.136(2), 168–175 (2000).
   PubMed Web of Science ®Google Scholar
• Bracco Neto H, Farhat CK, Tregnaghi MW et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Pediatr. Infect. Dis. J.28(5), 365–371 (2009).
   PubMed Web of Science ®Google Scholar